Menu

Breast cancer

3,150 trials in this section

Recruiting NCT04230109

Sacituzumab Govitecan In TNBC

Phase II Interventional United States

Invasive Breast Cancer · Triple Negative Breast Cancer · ER-Negative Breast Cancer